This sugar-coated therapy boosted survival against deadly brain cancer by 50% in mice
Scientists at Oregon State University created sugar-coated lipid nanoparticles that can cross the blood-brain barrier to deliver genetic therapy to glioblastoma tumors. In mouse models, this targeted approach increased survival rates by 50% by effectively suppressing tumor growth.
Why it matters
Glioblastoma is notoriously difficult to treat due to the blood-brain barrier; this delivery method could significantly improve outcomes for aggressive brain cancers.
Researchers at Oregon State University have developed a promising experimental strategy for treating glioblastoma, the most aggressive form of brain cancer. Fewer than 30% of patients survive for two years after diagnosis.
The report focuses on medical research outcomes and methodology without ideological bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in